• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Glenmark Pharmaceuticals - Articles and news items

FDA clears Glenmark’s HER2+ cancer drug for Phase I trial

Industry news / 3 January 2017 / Niamh Louise Marriott, Digital Editor

Preclinical studies suggest GBR 1302 may have activity against a range of HER2-expressing tumour types, including breast, gastric and other cancers…

Sun shines on Indian generics manufacturers

Industry news, News / 3 April 2013 / GlobalData

India is becoming a key market for generic medicines…

Glenmark Pharmaceuticals logo

Sanofi and Glenmark Pharmaceuticals sign license agreement on Novel Monoclonal Antibody for Crohn’s Disease

Industry news, News / 17 May 2011 / Glenmark Pharmaceuticals

Sanofi to develop molecule for Crohn’s Disease & other anti-inflammatory conditions…